Allegheny Financial Group lessened its stake in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 48.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,654 shares of the semiconductor company's stock after selling 8,064 shares during the quarter. Synopsys comprises approximately 0.6% of Allegheny Financial Group's portfolio, making the stock its 29th biggest position. Allegheny Financial Group's holdings in Synopsys were worth $4,065,000 at the end of the most recent reporting period.
Other large investors have also modified their holdings of the company. Stanley Laman Group Ltd. increased its holdings in Synopsys by 542.9% in the 3rd quarter. Stanley Laman Group Ltd. now owns 12,877 shares of the semiconductor company's stock valued at $6,353,000 after buying an additional 10,874 shares during the period. Empirical Asset Management LLC bought a new stake in Synopsys during the 3rd quarter worth approximately $773,000. Strategic Advisors LLC grew its position in Synopsys by 76.3% during the 3rd quarter. Strategic Advisors LLC now owns 7,578 shares of the semiconductor company's stock worth $3,739,000 after acquiring an additional 3,279 shares during the last quarter. China Universal Asset Management Co. Ltd. grew its holdings in Synopsys by 31.8% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 14,810 shares of the semiconductor company's stock worth $6,957,000 after acquiring an additional 3,575 shares during the last quarter. Finally, OVERSEA CHINESE BANKING Corp Ltd grew its holdings in Synopsys by 24.8% during the 3rd quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 23,970 shares of the semiconductor company's stock worth $11,827,000 after acquiring an additional 4,759 shares during the last quarter. Hedge funds and other institutional investors own 85.47% of the company's stock.
Analyst Upgrades and Downgrades
A number of research analysts have commented on the company. Wells Fargo & Company decreased their price objective on Synopsys from $500.00 to $450.00 and set an "equal weight" rating on the stock in a research report on Thursday, February 26th. The Goldman Sachs Group set a $600.00 target price on Synopsys and gave the stock a "buy" rating in a report on Wednesday, February 25th. HSBC lowered shares of Synopsys from a "buy" rating to a "hold" rating and set a $455.00 price target on the stock. in a research note on Friday, February 20th. Piper Sandler cut their price target on Synopsys from $520.00 to $430.00 and set a "neutral" rating on the stock in a report on Thursday, February 26th. Finally, Needham & Company LLC restated a "buy" rating on shares of Synopsys in a report on Thursday, February 26th. Eight equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Synopsys currently has a consensus rating of "Hold" and a consensus price target of $531.00.
Read Our Latest Stock Report on SNPS
Synopsys Stock Performance
Shares of SNPS stock opened at $497.50 on Tuesday. The company's fifty day simple moving average is $430.07 and its 200-day simple moving average is $445.71. The company has a quick ratio of 1.26, a current ratio of 1.36 and a debt-to-equity ratio of 0.33. The firm has a market cap of $95.30 billion, a PE ratio of 77.25, a P/E/G ratio of 3.99 and a beta of 1.25. Synopsys, Inc. has a 12 month low of $376.18 and a 12 month high of $651.73.
Synopsys (NASDAQ:SNPS - Get Free Report) last announced its quarterly earnings data on Wednesday, February 25th. The semiconductor company reported $3.77 EPS for the quarter, topping analysts' consensus estimates of $3.56 by $0.21. The business had revenue of $2.41 billion for the quarter, compared to analyst estimates of $2.39 billion. Synopsys had a net margin of 13.76% and a return on equity of 6.83%. The firm's revenue for the quarter was up 65.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $3.03 earnings per share. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. Equities research analysts expect that Synopsys, Inc. will post 10.3 EPS for the current fiscal year.
Synopsys Profile
(
Free Report)
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.